Zhitong Financial App News, Ju Ophthalmology (02219) issued an announcement that the over-allotment option mentioned in the prospectus has been partially exercised by the Joint Global Coordinator (for itself and on behalf of the international underwriter) on July 29, 2021, involving a total of 20.125 million additional shares, accounting for about 14.64% of the new shares and about 11.77% of the offer shares initially available for subscription under the global offering before any exercise of the over-allotment option.

The over-allotment shares will be issued at HK $10.60 per offer share (i.e. the issue price per share under the Global offer) to facilitate the restitution of some of the 20.625 million shares borrowed from Xiwang Medical Management to cover the over-allotment of the International offer under the share borrowing Agreement.

The company further announced that the stable price period for the global offering ended on 29 July 2021, the 30th day after the deadline for submitting applications for the Hong Kong Public offering.